Literature DB >> 12676784

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.

Vahid Asnafi1, Isabelle Radford-Weiss, Nicole Dastugue, Chantal Bayle, Daniel Leboeuf, Christiane Charrin, Richard Garand, Marina Lafage-Pochitaloff, Eric Delabesse, Agnes Buzyn, Xavier Troussard, Elizabeth Macintyre.   

Abstract

The t(10;11)(p13-14;q14-21) associated with CALM-AF10 is considered to be rare and associated with a variety of acute lymphoid and myeloid leukemias. Twelve (9%) of 131 unselected T-cell acute lymphoid leukemias (T-ALLs) expressed CALM-AF10 by reverse transcription-polymerase chain reaction or fluorescence in situ hybridization (or both), including 8% of children and 10% of adults, of whom only half demonstrated a t(10;11) by classical cytogenetics. CALM-AF10 was not found in T-cell-receptor alphabeta (TCRalphabeta) lineage T-ALLs, as defined by expression of TCRalphabeta, cytoplasmic TCRbeta, or TCRbetaVDJ rearrangement in immature cytoplasmic TCRbeta- cases, compared with 19% of TCRgammadelta T-ALLs and 33% of immature delta/gamma T-ALLs. The latter differed from their CALM-AF10- immature counterparts by a CD5+/CD2-phenotype, as found in TCRgammadelta but not TCRalphabeta T-ALLs and in their TCRgamma and TCRdelta configurations, altogether suggesting that CALM-AF10+ immature delta/gammaT-ALLs are TCRgammadelta precursors and that, within T-ALL, CALM-AF10 is specific for this lineage. Nine of 12 immature CALM-AF10 T-ALLs demonstrated 3' fusion transcripts, whereas 6 of 7 TCRgammadelta T-ALLs demonstrated 5' fusion transcripts. The latter retain the AF10 extended LAP/PHD domain necessary for homo-oligomerization. All 8 patients with CALM-AF10+TCRgammadelta T-ALLs are alive, compared with only 3 of 12 with immature CALM-AF10+ T-ALLs. Six CALM-AF10+ non-T acute leukemias all expressed CD7 and demonstrated T-restricted TCRdelta rearrangements, suggesting that they may also be related to the TCRgammadelta lineage. CALM-AF10 is therefore the most common fusion protein in T-ALL. It requires molecular and immunophenotypic characterization for appropriate prognostic evaluation and should be included in diagnostic screening panels of T-ALL and immature acute leukemias. Analysis of immature CALM-AF10+ leukemias will also facilitate analysis of the early stages of development of the TCRgammadelta lineage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676784     DOI: 10.1182/blood-2002-09-2913

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation.

Authors:  Agus Darwanto; Matthew P Curtis; Matthew Schrag; Wolff Kirsch; Peng Liu; Guoliang Xu; Jonathan W Neidigh; Kangling Zhang
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

2.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

3.  The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy.

Authors:  Valeria Tosello; Adolfo A Ferrando
Journal:  Ther Adv Hematol       Date:  2013-06

4.  Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.

Authors:  Qian Wang; Huiying Qiu; Hui Jiang; Lili Wu; Shasha Dong; Jinlan Pan; Wenjuan Wang; Nana Ping; Jing Xia; Aining Sun; Depei Wu; Yongquan Xue; Hans G Drexler; Roderick A F Macleod; Suning Chen
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

5.  Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.

Authors:  Sarah H Beachy; Masahiro Onozawa; Deborah Silverman; Yang Jo Chung; Mariela Martinez Rivera; Peter D Aplan
Journal:  Exp Hematol       Date:  2013-02-19       Impact factor: 3.084

6.  Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL.

Authors:  Jonathan Bond; Aurélie Bergon; Amandine Durand; Isabelle Tigaud; Xavier Thomas; Vahid Asnafi; Salvatore Spicuglia; Elizabeth Macintyre
Journal:  Blood       Date:  2014-11-06       Impact factor: 22.113

7.  Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance.

Authors:  Liat Goldberg; Sheryl M Gough; Fan Lee; Christine Dang; Robert L Walker; Yuelin J Zhu; Sven Bilke; Marbin Pineda; Masahiro Onozawa; Yang Jo Chung; Paul S Meltzer; Peter D Aplan
Journal:  Genes Chromosomes Cancer       Date:  2017-03-31       Impact factor: 5.006

8.  TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome.

Authors:  P Villarese; C Lours; A Trinquand; S Le Noir; M Belhocine; L Lhermitte; A Cieslak; M Tesio; A Petit; M LeLorch; S Spicuglia; N Ifrah; H Dombret; A W Langerak; N Boissel; E Macintyre; V Asnafi
Journal:  Leukemia       Date:  2017-06-08       Impact factor: 11.528

9.  KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.

Authors:  Fida Khater; Mathieu Lajoie; Sylvie Langlois; Jasmine Healy; Sonia Cellot; Chantal Richer; Patrick Beaulieu; Pascal St-Onge; Virginie Saillour; Mark Minden; Monia Marzouki; Maja Krajinovic; Henrique Bittencourt; Daniel Sinnett
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

Review 10.  The molecular basis of T cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Adolfo Ferrando
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.